Navigation Links
R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
Date:9/10/2007

art 1 is to explore the effect of food on the pharmacokinetics of

R7128. Preliminary data from the single ascending dose portion of the

study indicate:

-- All doses of R7128 studied were generally safe and well-tolerated.

-- All patients completed the study, and none experienced

gastrointestinal adverse events or serious adverse events during

the study.

-- No hematological or laboratory abnormalities of clinical

significance were noted.

- Part 2 is a multiple ascending dose study of R7128 conducted in 40

patients chronically infected with HCV genotype 1 who have previously

failed interferon therapy. The primary objective of Part 2 is to

assess the safety, tolerability and pharmacokinetics of R7128 after

once-daily or twice-daily dosing for 14 days. The secondary objective

is to assess antiviral activity by measuring the change in HCV RNA.

About Hepatitis C

Hepatitis C is a blood-borne infectious disease of the liver and is a leading cause of chronic liver disease and liver transplants. The World Health Organization estimates that nearly 180 million people worldwide, or approximately 3% of the world's population, are infected with hepatitis C virus (HCV). The CDC has reported that almost four million people in the United States have been infected with HCV, of whom 2.7 million are chronically infected.

Contact

Alan Roemer, Vice President

Investor Relations & Corporate Communications

alan.roemer@pharmasset.com

Office: (609) 613-4125

Forward-Looking Statements

Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
4. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
5. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
6. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
7. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
8. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
9. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
10. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015  The 2015 LiftWalker, developed by ... Systems Corporation ball drive actuator to give the ... the industry,s largest selection of electromechanical linear actuators ... of industries, including medical devices. ... wheelchair-bound as well as people who just need ...
(Date:5/27/2015)... -- Medical Device Contract Manufacturing - new ... Where is the market for medical ... prospects for this market and medical device ... shows you potential revenues and other trends to 2025, ... page report provides 127 tables, charts, and graphs. Discover ...
(Date:5/27/2015)... , May 27, 2015 In a ... Canadian International Pharmacy Association (CIPA) found ... from licensed Canadian pharmacies. Approximately 64% of respondents purchase ... from a non-U.S. pharmacy due to costs of ... covered under their insurance plan.   Many ...
Breaking Medicine Technology:Innovative Technology Liberates the Wheelchair-Bound 2Medical Device Contract Manufacturing Market Forecast 2015-2025 2Medical Device Contract Manufacturing Market Forecast 2015-2025 3Medical Device Contract Manufacturing Market Forecast 2015-2025 4Medical Device Contract Manufacturing Market Forecast 2015-2025 5Medical Device Contract Manufacturing Market Forecast 2015-2025 6Medical Device Contract Manufacturing Market Forecast 2015-2025 7Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 2Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 3
... Sept. 17 Biodel Inc. (Nasdaq: BIOD ) ... board of directors.  Mr. Urciuoli is chairman of ArcherGroup, a ... to the board of the newly-formed Kroll Bond Rating Agency. ... former director of Kroll, Inc.  He spent 30 years at ...
... 16 Alere Inc. (NYSE: ALR ) announced ... of senior subordinated notes due 2018, it entered into a ... September 15, 2010.  The size of the offering was increased ... coupon of 8.625% and are being offered at 100.0% of ...
Cached Medicine Technology:Biodel Appoints Arthur Urciuoli to its Board of Directors 2Biodel Appoints Arthur Urciuoli to its Board of Directors 3Alere Inc. Announces Pricing of Senior Subordinated Notes Offering; Offering Size Increased to $400.0 Million 2
(Date:5/27/2015)... Mountain View, CA (PRWEB) May 27, 2015 ... Napa Valley will be able to reach for Organic Coconut ... 2015. Coco Libre will be available at VIP areas, artist ... will also be available at area hotels and on festival ... as a partner this year,” said Noa Elan, Director of ...
(Date:5/27/2015)... 27, 2015 Genius Monkey is pleased ... programmatic marketing technology, they have boosted sales for the ... a regional level for seven Utah-based dealers. , ... television and radio media. In 2014 the Utah Honda ... of Genius Monkey , shifted their marketing campaigns ...
(Date:5/27/2015)... May 27, 2015 With a prevalently ... poll conducted during the "ACA - Controlling the Chaos" ... 75% are currently in the process of researching ... were confidently prepared for the reporting mandates. , According ... the webinar, those who are currently vetting ACA reporting ...
(Date:5/27/2015)... Portland, Oregon (PRWEB) May 27, 2015 ... treatments in North America, is offering free design advice ... the outside environment. , “Light pollution caused by ... can cause a restless night’s sleep, said Kim Rush, ... residents of numerous cities across North America with recently ...
(Date:5/27/2015)... Louisville, KY (PRWEB) May 27, 2015 ... or worse because of lack of compliance documentation or ... a recycler in Miami, a propane gas company in ... doling out fines for incidents and accidents due to ... System (LMS) is proud to introduce the new ...
Breaking Medicine News(10 mins):Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2Health News:Decorview Helps Homeowners Combat Light Pollution 2Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 2Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 3
... That Indicate Egg Quality and QuantityPRINCETON, N.J., April 6 ... buy at retail, a new test that can help ... pregnant. The First Response(R) Fertility Test for Women is ... stimulating hormone (FSH) levels to evaluate ovarian reserve - ...
... N.J., April 6 The following was released today by Dystonia ... Wicke d & the ... a Caus e - Anthony Galde of Wicke ... 2nd Annual Curtain Call for a Cause on behalf of dystonia, ...
... Rheumatoid arthritis (RA) is a systemic disease or an ... joints through the thin layer of cells called the synovium ... of RA are swollen joints and crippling stiffness, particularly of ... of appetite and also impedes mobility and quality of life. ...
... - a first-of-its-kind training program to help refractive & cataract surgeons ... boot camp session will be held on June 5th in Chicago ... ... April 6, 2009 -- Premium Lens Boot Camp™ - a first-of-its-kind ...
... inspired to start an internet weblog about health. Dr. Davon Jacobson, ... and truth on various health topics. , ... Greenwich, ... a general practitioner and establishing a private medical practice, Dr. Davon ...
... web-based delivery of clinical data enable community hospital staff ... April 5 Siemens ( ... its MedSeries4 Clinical Suite enterprise-wide solution, which ... access vital clinical data in three clicks or less. ...
Cached Medicine News:Health News:Video: New First Response(R) Fertility Test Helps Women Answer the Question: Am I Able to Get Pregnant? 2Health News:Video: New First Response(R) Fertility Test Helps Women Answer the Question: Am I Able to Get Pregnant? 3Health News:Video: New First Response(R) Fertility Test Helps Women Answer the Question: Am I Able to Get Pregnant? 4Health News:Broadway Comes to New Jersey 2Health News:Rheumatoid Arthritis Therapeutics in Thailand 2Health News:Rheumatoid Arthritis Therapeutics in Thailand 3Health News:Premium Lens Boot Camp™ Helps Refractive Surgeons Grow Their Premium IOL Practice 2Health News:Medical Doctor Enhances Health Awareness through Online Blogging 2Health News:Community Hospitals Remain Competitive with Latest Enhancement to Siemens' MedSeries4 Clinical Suite 2Health News:Community Hospitals Remain Competitive with Latest Enhancement to Siemens' MedSeries4 Clinical Suite 3Health News:Community Hospitals Remain Competitive with Latest Enhancement to Siemens' MedSeries4 Clinical Suite 4
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Steroid-eluting, screw-in pacing lead...
... one of the world's thinnest, ... a 7 F introducer, the ... designed to lower the incidence ... introduction in smaller, more tortuous ...
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase....
Medicine Products: